Addus HomeCare Announces Fourth Quarter and Year End 2022 Financial Results
Addus HomeCare Corporation (NASDAQ: ADUS) reported Q4 and full-year 2022 financial results, highlighting a 10.0% revenue increase to $247.1 million in Q4 and $951.1 million for the year. Net income rose to $14.8 million in Q4, with adjusted earnings per diluted share at $1.11. Adjusted EBITDA for Q4 grew 5.4% to $28.2 million. Despite challenges like staffing shortages and inflation, Addus maintained cash flow from operations at $24.3 million in Q4. The company continues to invest in technology and acquisitions, anticipating a favorable acquisition environment in 2023, with a strong focus on expanding clinical services.
- 10.0% revenue growth in Q4 to $247.1 million.
- Net income increased to $14.8 million, up from $13.1 million year-over-year.
- Adjusted EBITDA rose 5.4% to $28.2 million in Q4.
- Annual revenue reached $951.1 million, a 10.0% increase compared to 2021.
- Strong cash flow from operations of $24.3 million in Q4 and $105.1 million for the full year.
- Hospice same-store revenues decreased by 4.9% compared to the same quarter last year.
- Inflationary pressures and staffing shortages continue to challenge operations.
Fourth Quarter 2022 Highlights:
-
Revenues Grow
10.0% to$247.1 Million -
Net Income of
, or$14.8 Million per Diluted Share$0.91 -
Adjusted Earnings per Diluted Share Increases to
$1.11 -
Adjusted EBITDA Increases
5.4% to$28.2 Million -
Cash flow from operations of
$24.3 Million
Overview
Net service revenues were
For 2022, net service revenues increased
Commenting on the results,
Cash and Liquidity
As of
Looking Ahead
Allison continued, “Our strong balance sheet and disciplined approach to financial management provides us with the capital to continue investing in our business, including new technology to support the work of our caregivers and enhance our recruiting and hiring processes to meet our growing staffing needs. We remain focused on our acquisition strategy and continue to look for opportunities that fit our overall growth strategy and meet our primary objective to expand our clinical services capabilities in markets where we already have a strong personal care presence. We were pleased to add approximately
“We are proud of our ability to deliver strong results despite some lingering headwinds related to the pandemic and the challenging labor market for health care providers. Demand for our services continues to grow, reflecting a greater societal awareness of the value of home-based care as the safest and most cost-effective option for many individuals. Addus is well-positioned to meet this demand across the care continuum, and we have a proven operating model that has delivered consistent and favorable results. Importantly, we have a dedicated team of frontline caregivers, who support our mission and continue to work tirelessly to provide quality care and support for our patients and their families. Working together, we look forward to the opportunities ahead for Addus in 2023 as we extend our market reach and deliver greater value to our shareholders.”
Non-GAAP Financial Measures
The information provided in this release includes adjusted net income, adjusted EBITDA and adjusted net income per diluted share, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition and de novo expenses, stock-based compensation expenses, restructure and other non-recurring costs, gain or loss on the sale of assets, and retroactive rate increases from
Conference Call
Addus will host a conference call on
A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast.
Forward-Looking Statements
Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any security breaches, cyber-attacks, loss of data or cybersecurity threats or incidents, and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the
About
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | |||||||||||||||
Condensed Consolidated Statements of Income | |||||||||||||||
(amounts and shares in thousands, except per share data) | |||||||||||||||
(Unaudited) | |||||||||||||||
Income Statement Information: | For the Three Months Ended |
For the Twelve Months Ended |
|||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net service revenues | $ |
247,050 |
|
$ |
224,642 |
|
$ |
951,120 |
|
$ |
864,499 |
|
|||
Cost of service revenues |
|
168,281 |
|
|
151,847 |
|
|
651,381 |
|
|
594,651 |
|
|||
Gross profit |
|
78,769 |
|
|
72,795 |
|
|
299,739 |
|
|
269,848 |
|
|||
|
31.9 |
% |
|
32.4 |
% |
|
31.5 |
% |
|
31.2 |
% |
||||
General and administrative expenses |
|
54,466 |
|
|
49,537 |
|
|
216,942 |
|
|
189,418 |
|
|||
Depreciation and amortization |
|
3,489 |
|
|
3,900 |
|
|
14,060 |
|
|
14,494 |
|
|||
Total operating expenses |
|
57,955 |
|
|
53,437 |
|
|
231,002 |
|
|
203,912 |
|
|||
Operating income |
|
20,814 |
|
|
19,358 |
|
|
68,737 |
|
|
65,936 |
|
|||
Total interest expense, net |
|
2,537 |
|
|
1,536 |
|
|
8,566 |
|
|
5,538 |
|
|||
Income before income taxes |
|
18,277 |
|
|
17,822 |
|
|
60,171 |
|
|
60,398 |
|
|||
Income tax expense |
|
3,515 |
|
|
4,764 |
|
|
14,146 |
|
|
15,272 |
|
|||
Net income | $ |
14,762 |
|
$ |
13,058 |
|
$ |
46,025 |
|
$ |
45,126 |
|
|||
Net income per diluted share: | |||||||||||||||
Continuing Operations | $ |
0.91 |
|
$ |
0.81 |
|
$ |
2.84 |
|
$ |
2.81 |
|
|||
Weighted average number of common shares outstanding: | |||||||||||||||
Diluted |
|
16,258 |
|
|
16,059 |
|
|
16,181 |
|
|
16,064 |
|
|||
Cash Flow Information: | For the Three Months Ended |
For the Twelve Months Ended |
|||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net cash provided by operating activities | $ |
24,292 |
|
$ |
25,201 |
|
$ |
105,110 |
|
$ |
39,488 |
|
|||
Net cash used in investing activities |
|
(19,236 |
) |
|
(9,582 |
) |
|
(106,590 |
) |
|
(42,015 |
) |
|||
Net cash (used in) provided by financing activities |
|
(30,739 |
) |
|
897 |
|
|
(87,454 |
) |
|
26,344 |
|
|||
Net change in cash |
|
(25,683 |
) |
|
16,516 |
|
|
(88,934 |
) |
|
23,817 |
|
|||
Cash at the beginning of the period |
|
105,644 |
|
|
152,379 |
|
|
168,895 |
|
|
145,078 |
|
|||
Cash at the end of the period | $ |
79,961 |
|
$ |
168,895 |
|
$ |
79,961 |
|
$ |
168,895 |
|
Condensed Consolidated Balance Sheets | |||||
(Amounts in thousands) | |||||
(Unaudited) | |||||
2022 |
2021 |
||||
Assets | |||||
Current assets | |||||
Cash | $ |
79,961 |
$ |
168,895 |
|
Accounts receivable, net |
|
125,501 |
|
136,955 |
|
Prepaid expenses and other current assets |
|
17,345 |
|
18,491 |
|
Total current assets |
|
222,807 |
|
324,341 |
|
Property and equipment, net |
|
21,182 |
|
18,483 |
|
Other assets | |||||
|
582,837 |
|
504,392 |
||
Intangible assets, net |
|
72,188 |
|
64,321 |
|
Operating lease assets |
|
38,980 |
|
36,048 |
|
Total other assets |
|
694,005 |
|
604,761 |
|
Total assets | $ |
937,994 |
$ |
947,585 |
|
Liabilities and stockholders' equity | |||||
Current liabilities | |||||
Accounts payable | $ |
22,092 |
$ |
19,358 |
|
Accrued payroll |
|
44,937 |
|
44,083 |
|
Accrued expenses |
|
38,308 |
|
37,077 |
|
Government stimulus advance |
|
12,912 |
|
4,173 |
|
Accrued workers compensation |
|
12,897 |
|
12,998 |
|
Total current liabilities |
|
131,146 |
|
117,689 |
|
Long-term debt, less current portion, net of debt issuance costs |
|
131,772 |
|
220,912 |
|
Long-term lease liability, less current portion |
|
35,479 |
|
32,859 |
|
Other long-term liabilities |
|
6,057 |
|
1,781 |
|
Total long-term liabilities |
|
173,308 |
|
255,552 |
|
Total liabilities |
|
304,454 |
|
373,241 |
|
Total stockholders' equity |
|
633,540 |
|
574,344 |
|
Total liabilities and stockholders' equity | $ |
937,994 |
$ |
947,585 |
|
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | |||||||||||
Net Service Revenue by Segment | |||||||||||
(Amounts in thousands) | |||||||||||
(Unaudited) | |||||||||||
For the Three Months Ended |
For the Twelve Months Ended |
||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Net Service Revenues by Segment | |||||||||||
Personal Care | $ |
183,365 |
$ |
175,110 |
$ |
706,507 |
$ |
685,854 |
|||
Hospice |
|
50,612 |
|
40,155 |
|
201,772 |
|
152,253 |
|||
|
13,073 |
|
9,377 |
|
42,841 |
|
26,392 |
||||
Total Revenue | $ |
247,050 |
$ |
224,642 |
$ |
951,120 |
$ |
864,499 |
|||
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | ||||||||||||||||
Key Statistical and Financial Data (Unaudited) | ||||||||||||||||
For the Three Months Ended |
For the Twelve Months Ended |
|||||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
||||||||
General | ||||||||||||||||
Personal Care | ||||||||||||||||
States served at period end |
|
- |
|
|
- |
|
|
22 |
|
|
22 |
|
||||
Locations at period end |
|
- |
|
|
- |
|
|
156 |
|
|
162 |
|
||||
Average billable census total |
|
38,169 |
|
|
37,405 |
|
|
37,482 |
|
|
38,051 |
|
||||
Billable hours (in thousands) |
|
7,465 |
|
|
7,425 |
|
|
29,412 |
|
|
30,151 |
|
||||
Average billable hours per census per month |
|
65.0 |
|
|
65.8 |
|
|
65.1 |
|
|
65.7 |
|
||||
Billable hours per business day |
|
114,849 |
|
|
112,498 |
|
|
113,122 |
|
|
115,521 |
|
||||
Revenues per billable hour | $ |
24.48 |
|
$ |
23.28 |
|
$ |
23.91 |
$ |
22.71 |
|
|||||
Organic growth | ||||||||||||||||
- Revenue |
|
7.9 |
|
% |
|
8.0 |
|
% |
|
4.6 |
|
% |
|
7.3 |
|
% |
Hospice | ||||||||||||||||
Locations served at period end |
|
- |
|
|
- |
|
|
33 |
|
|
32 |
|
||||
Admissions |
|
3,393 |
|
|
2,381 |
|
|
13,171 |
|
|
9,592 |
|
||||
Average daily census |
|
3,213 |
|
|
2,635 |
|
|
3,279 |
|
|
2,561 |
|
||||
Average discharge length of stay |
|
90.2 |
|
|
99.3 |
|
|
87.7 |
|
|
96.5 |
|
||||
Patient days |
|
295,619 |
|
|
249,266 |
|
|
1,176,193 |
|
|
923,014 |
|
||||
Revenue per patient day | $ |
171.21 |
|
$ |
165.64 |
|
$ |
171.55 |
|
$ |
164.95 |
|
||||
Organic growth | ||||||||||||||||
- Revenue |
|
(4.9 |
) |
% |
|
1.3 |
|
% |
|
0.4 |
|
% |
|
(6.2 |
) |
% |
- Average daily census |
|
(0.9 |
) |
% |
|
(1.4 |
) |
% |
|
1.9 |
|
% |
|
(11.2 |
) |
% |
Locations served at period end |
|
- |
|
|
- |
|
|
13 |
|
|
12 |
|
||||
New Admissions |
|
4,081 |
|
|
3,819 |
|
|
14,452 |
|
|
8,781 |
|
||||
Recertifications |
|
1,631 |
|
|
1,071 |
|
|
5,838 |
|
|
3,547 |
|
||||
Total Volume |
|
5,712 |
|
|
4,890 |
|
|
20,290 |
|
|
12,328 |
|
||||
Visits |
|
88,046 |
|
|
68,741 |
|
|
293,381 |
|
|
183,951 |
|
||||
Organic growth | ||||||||||||||||
- Revenue |
|
8.3 |
|
% |
|
7.1 |
|
% |
|
8.2 |
|
% |
|
11.3 |
|
% |
- New Admissions |
|
(12.8 |
) |
% |
|
21.0 |
|
% |
|
16.4 |
|
% |
|
23.0 |
|
% |
- Volume |
|
(1.8 |
) |
% |
|
15.0 |
|
% |
|
18.7 |
|
% |
|
17.4 |
|
% |
Percentage of Revenues by Payor: | ||||||||||||||||
Personal Care | ||||||||||||||||
State, local and other governmental programs |
|
49.3 |
|
% |
|
48.7 |
|
% |
|
49.3 |
|
% |
|
49.3 |
|
% |
Managed care organizations |
|
46.7 |
|
|
46.0 |
|
|
46.3 |
|
|
45.5 |
|
||||
Private duty |
|
2.5 |
|
|
2.9 |
|
|
2.6 |
|
|
2.9 |
|
||||
Commercial |
|
0.9 |
|
|
1.4 |
|
|
1.1 |
|
|
1.4 |
|
||||
Other |
|
0.6 |
|
% |
|
1.0 |
|
% |
|
0.7 |
|
% |
|
0.9 |
|
% |
Hospice | ||||||||||||||||
Medicare |
|
91.3 |
|
% |
|
93.1 |
|
% |
|
90.9 |
|
% |
|
93.3 |
|
% |
Commercial |
|
4.5 |
|
|
3.2 |
|
|
5.0 |
|
|
2.6 |
|
||||
Managed care organizations |
|
3.7 |
|
|
3.2 |
|
|
3.6 |
|
|
3.7 |
|
||||
Other |
|
0.5 |
|
% |
|
0.5 |
|
% |
|
0.5 |
|
% |
|
0.4 |
|
% |
Medicare |
|
74.9 |
|
% |
|
75.1 |
|
% |
|
73.5 |
|
% |
|
78.4 |
|
% |
Managed care organizations |
|
18.9 |
|
|
17.0 |
|
|
20.3 |
|
|
16.9 |
|
||||
Commercial |
|
6.0 |
|
|
7.8 |
|
|
6.0 |
|
|
4.6 |
|
||||
Other |
|
0.2 |
|
% |
|
0.1 |
|
% |
|
0.2 |
|
% |
|
0.1 |
|
% |
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | |||||||||||||||
Reconciliation of Non-GAAP Financial Measures | |||||||||||||||
(Amounts in thousands, except per share data) | |||||||||||||||
(Unaudited) (1) | |||||||||||||||
For the Three Months Ended |
For the Twelve Months Ended |
||||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||||
Reconciliation of Adjusted EBITDA to Net Income: (2) | |||||||||||||||
Net income | $ |
14,762 |
|
$ |
13,058 |
|
$ |
46,025 |
|
$ |
45,126 |
|
|||
Interest expense, net |
|
2,537 |
|
|
1,536 |
|
|
8,566 |
|
|
5,538 |
|
|||
(Gain) loss on sale of assets |
|
(33 |
) |
|
9 |
|
|
(60 |
) |
|
25 |
|
|||
Income tax expense |
|
3,515 |
|
|
4,764 |
|
|
14,146 |
|
|
15,272 |
|
|||
Depreciation and amortization |
|
3,489 |
|
|
3,900 |
|
|
14,060 |
|
|
14,494 |
|
|||
COVID-19 expense, net |
|
- |
|
|
- |
|
|
- |
|
|
(591 |
) |
|||
|
- |
|
|
(1,005 |
) |
|
- |
|
|
- |
|
||||
Acquisition and de novo expenses |
|
1,155 |
|
|
1,923 |
|
|
7,657 |
|
|
7,306 |
|
|||
Stock-based compensation expense |
|
2,680 |
|
|
2,329 |
|
|
10,625 |
|
|
9,434 |
|
|||
Restructure and other non-recurring costs |
|
143 |
|
|
200 |
|
|
461 |
|
|
1,057 |
|
|||
Adjusted EBITDA | $ |
28,248 |
|
$ |
26,714 |
|
$ |
101,480 |
|
$ |
97,661 |
|
|||
Reconciliation of Adjusted Net Income to Net Income: (3) | |||||||||||||||
Net income | $ |
14,762 |
|
$ |
13,058 |
|
$ |
46,025 |
|
$ |
45,126 |
|
|||
Loss on sale of assets, net of tax |
|
(26 |
) |
|
7 |
|
|
(46 |
) |
|
19 |
|
|||
COVID-19 expense, net of tax |
|
- |
|
|
- |
|
|
- |
|
|
(445 |
) |
|||
|
- |
|
|
(739 |
) |
|
- |
|
|
- |
|
||||
Acquisition and de novo expenses, net of tax |
|
1,005 |
|
|
1,413 |
|
|
5,857 |
|
|
5,750 |
|
|||
Stock-based compensation expense, net of tax |
|
2,198 |
|
|
1,712 |
|
|
8,126 |
|
|
7,049 |
|
|||
Restructuring and other non-recurring costs, net of tax |
|
116 |
|
|
147 |
|
|
353 |
|
|
790 |
|
|||
Adjusted Net Income | $ |
18,055 |
|
$ |
15,598 |
|
$ |
60,315 |
|
$ |
58,289 |
|
|||
Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (4) | |||||||||||||||
Net income per diluted share | $ |
0.91 |
|
$ |
0.81 |
|
$ |
2.84 |
|
$ |
2.81 |
|
|||
Loss on sale of assets per diluted share |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|||
COVID-19 expense per diluted share |
|
- |
|
|
- |
|
|
- |
|
|
(0.03 |
) |
|||
|
- |
|
|
(0.05 |
) |
|
- |
|
|
- |
|
||||
Acquisition and de novo expenses per diluted share |
|
0.06 |
|
|
0.09 |
|
|
0.36 |
|
|
0.36 |
|
|||
Restructure and other non-recurring costs per diluted share |
|
0.01 |
|
|
0.01 |
|
|
0.02 |
|
|
0.05 |
|
|||
Stock-based compensation expense per diluted share |
|
0.13 |
|
|
0.11 |
|
|
0.51 |
|
|
0.44 |
|
|||
Adjusted net income per diluted share | $ |
1.11 |
|
$ |
0.97 |
|
$ |
3.73 |
|
$ |
3.63 |
|
|||
Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (5) | |||||||||||||||
Net service revenues | $ |
247,050 |
|
$ |
224,642 |
|
$ |
951,120 |
|
$ |
864,499 |
|
|||
Revenues associated with the closure of certain sites |
|
- |
|
|
(368 |
) |
|
(761 |
) |
|
(2,184 |
) |
|||
Adjusted net service revenues | $ |
247,050 |
|
$ |
224,274 |
|
$ |
950,359 |
|
$ |
862,315 |
|
|||
Footnotes: |
(1) The Company defined adjusted net income, adjusted EBITDA, and adjusted diluted earnings per share to exclude net COVID expenses arising from the pandemic from the second quarter of 2020 to the first quarter of 2021. |
(2) We define Adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition and de novo expenses, stock-based compensation expense, restructure expenses and other non-recurring costs and loss on the sale of assets and retroactive rate increases from |
(3) We define Adjusted Net Income as net income before acquisition and de novo expenses, stock-based compensation expense, restructure and other non-recurring costs and gain or loss on the sale of assets and retroactive rate increases from |
(4) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition and de novo expenses, stock-based compensation expense and restructure and other non-recurring costs and loss on the sale of asset and retroactive rate increases from |
(5) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230227005708/en/
Executive Vice President, Chief Financial Officer
(469) 535-8200
investorrelations@addus.com
(615) 324-7346
dru.anderson@finnpartners.com
Source:
FAQ
What were Addus HomeCare's Q4 2022 earnings results?
How did Addus HomeCare perform in 2022?
What is the future outlook for Addus HomeCare?